ArticleGhana medical journal2025
Seroprevalences and factors associated with HBV, HCV and HIV infections in haemodialysis patients in rural areas of Gabon.
Article in Ghana medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To determine the seroprevalence and risk factors associated with hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) infection in rural haemodialysis patients at the Franceville haemodialysis centre in Gabon. Design: Retrospective, descriptive and analytical study using exhaustive sampling. Setting: Study conducted in a rural setting at the Franceville haemodialysis centre. Participants: One hundred nineteen records of haemodialysis patients in whom HBV, HCV and HIV serologies were performed. Four incomplete files were excluded. Main Outcome Measures: Viral infection, frequency of socioclinical characteristics, and univariate analysis. Results: One hundred and fifteen haemodialysis patients were included, 70 men and 45 women. The mean age was 46.64±18.74 years. The seroprevalence of infection was 1.74%, 4.35% and 12.17% for HBV, HCV and HIV, respectively. HBV infection was associated with previous dialysis (p=0.000; OR: 36.667; 95% CI [1.825-736.304]), duration of dialysis (p=0.019; OR: 0.055; 95% CI [0.003-11.324]), elevated transaminases (p=0.000; OR:112; 95% CI [3.738-3355.535]), and initial nephropathy (p=0.0157; OR:15.149; 95% CI [0.853-268.535]). HCV infection was associated with elevated transaminases (p=0.001; OR: 27.25; 95% CI [1.432-518.553]) and incident kidney disease (p=0.039; OR: 8.916; 95% CI [0.751-105.791]). HIV infection was associated with incident kidney disease (p=0.000; OR:6.852; 95% CI [1.982-23.689]). Conclusion: A low seroprevalence of HBV, HCV and a moderate seroprevalence of HIV infection has been reported in haemodialysis patients. Certain factors are associated with these infections. Systematic vaccination against HBV, responsible sexual behaviour and current and future strict hygiene measures will help to reduce viral infections in dialysis. Funding: None declared.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.